Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.32 | 4e-20 |
mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.34 | 2e-19 |
mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.31 | 7e-17 |
mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.27 | 5e-13 |
mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.24 | 2e-12 |
mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.38 | 9e-12 |
mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.24 | 4e-11 |
mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.23 | 9e-11 |
mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.23 | 7e-10 |
mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.22 | 9e-09 |